无再流(no-reflow)是指冠状动脉闭塞再通后,在无明显残余狭窄、夹层、痉挛或血栓形成等造成冠状动脉前向血流减少的因素,却无心肌组织有效灌注的现象...
基于138个网页-相关网页
Objective To evaluate the effects of tong xin-luo, adenosine, diltiazem and nicorandil on myocardial no-reflow in a mini-swine model of acute myocardial infarction (AMI) and reperfusion.
目的 评价通心络、腺苷、地尔硫卓和尼可地尔防治猪急性心肌梗死(AMI)再灌注后无再流的作用。
参考来源 - 急性心肌梗死再灌注后无再流及药物干预的实验研究·2,447,543篇论文数据,部分数据来源于NoteExpress
现对无再流现象的发病机制及诊断的研究进展进行综述。
The article reviews progress in research into pathogenesis, diagnosis of coronary no-reflow phenomenon.
无再流的机制尚不明确,并且不同患者的发病机制也可能不同。
The mechanisms responsible for no-reflow are uncertain and prevailing mechanism operating in the individual patient may also differ.
目的评价腺苷防治猪急性心肌梗死(AMI)再灌注后无再流的作用。
ObjectiveTo evaluate the beneficial effects of adenosine on myocardial no-reflow in a mini-swine model of acute myocardial infarction (AMI) and reperfusion.
应用推荐